Blockade of CCR4 breaks immune tolerance in chronic hepatitis B patients by modulating regulatory pathways
Abstract Background Immunotargets including checkpoint inhibitors and toll-like receptor 8 agonists have recently gained attention for the recovery of hepatitis B virus (HBV)-specific T cell exhaustion in chronic hepatitis B(CHB). Chemokine receptors have a similar significant role during viral infe...
Main Authors: | Arshi Khanam, Alip Ghosh, Joel V. Chua, Shyam Kottilil |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-04-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-023-04104-8 |
Similar Items
-
Aggravation of lipopolysaccharide-induced depressive-like behavior in CCR4-deficient mice
by: Yuta Hara, et al.
Published: (2023-11-01) -
mTOR-dependent translation drives tumor infiltrating CD8+ effector and CD4+ Treg cells expansion
by: Benedetta De Ponte Conti, et al.
Published: (2021-11-01) -
CCL19/CCR7 drives regulatory T cell migration and indicates poor prognosis in gastric cancer
by: Danhua Xu, et al.
Published: (2023-05-01) -
Dosing optimization of CCR4 immunotoxin for improved depletion of CCR4+ Treg in nonhuman primates
by: Zhaohui Wang, et al.
Published: (2018-08-01) -
CCL17‐CCR4 axis contributes to the onset of vitiligo in mice
by: He Li, et al.
Published: (2021-09-01)